Acute periapical abscesses in patients using selective serotonin reuptake inhibitors.
SSRIs
anxiety
apical disease
depression
endodontics
periapical abscess
Journal
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
ISSN: 1754-4505
Titre abrégé: Spec Care Dentist
Pays: United States
ID NLM: 8103755
Informations de publication
Date de publication:
06 Oct 2022
06 Oct 2022
Historique:
revised:
30
08
2022
received:
12
08
2022
accepted:
22
09
2022
entrez:
6
10
2022
pubmed:
7
10
2022
medline:
7
10
2022
Statut:
aheadofprint
Résumé
Depression and anxiety are severe health problems affecting millions of individuals worldwide. Consequently, the use of antidepressants has constantly been on a rise. Selective serotonin reuptake inhibitors (SSRIs) antidepressant are now commonly used due to fewer side effects as compared to other types of antidepressants. The aim of this study was to assess the prevalence of periapical abscesses (PAs)in patients using SSRIs. Integrated data of hospital patients was used. Data from the corresponding diagnosis codes for SSRIs and acute PAs was retrieved by searching the appropriate query in the database. The different diagnoses were coded using the international coding systems ICD 10. Diagnosis was made by calibrated dentists in a hospital setting based on clinical examination and imaging data. The odds ratio (OR) for the prevalence of acute PAs and its association with the use of SSRIs were calculated and analyzed statistically. It was found that the prevalence of acute PAs was significantly higher in patients using SSRIs as compared to the other hospital patient population. The OR was 2.8 and the difference between patients using SSRIs and patients who do not was statistically significant (p < .0001). Under the conditions of this study, it appears that the prevalence of acute PAs is higher in patients using SSRIs.
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This research did not receive any specific funding.
Informations de copyright
© 2022 Special Care Dentistry Association and Wiley Periodicals LLC.
Références
Marasine NR, Sankhi S, Lamichhane R, Marasini NR, Dangi NB. Use of antidepressants among patients diagnosed with depression: a scoping review. Biomed Res Int. 2021;2021:6699028. doi:10.1155/2021/6699028
World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization; 2017.
Grant BF. About 26% of people in the US have an anxiety, mood, impulse control, or substance disorder. Evid Based Ment Health. 2006;9:27. doi:10.1136/ebmh.9.1.27
Brody DJ, Gu Q. Antidepressant use among adults: United States, 2015-2018. NCHS data brief. 2020;377:1-8.
Karkare SU, Bhattacharjee S, Kamble P, Aparasu R. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother. 2011;9:109-119.
Bobo WV, Grossardt BR, Lapid MI, et al. Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. population. Pharmacol Res Perspect. 2019;7:e00461.
Kim JM, Stewart R, Kim SW, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. 2007;62:423-428.
Qaseem A, Barry MJ, Kansagara D, Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;164:350-359.
Hiemke C, Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000;85:11-28.
Lochmann D, Richardson T. Selective serotonin reuptake inhibitors. Handb Exp Pharmacol. 2019;250:135-144.
Shaughnessy AF. Selective serotonin reuptake inhibitors are probably the best first option for patients with panic disorder. Am Fam Physician. 2022;105(6). Online.
Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51:215-235.
Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60(4):4-11.
Gordon M, Melvin G. Selective serotonin re-uptake inhibitors- a review of the side effects in adolescents. Aust Fam Physician. 2013;42:620-623.
Haney EM, Warden SJ, Bliziotes MM. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone. 2010;46:13-17.
Wu X, Al-Abedalla K, Rastikerdar E, et al. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study. J Dent Res. 2014;93:1054-1061.
Bruyère O, Reginster JY. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome. Endocrine. 2015;48:65-68.
Saraykar S, John V, Cao B, et al. Association of selective serotonin reuptake inhibitors and bone mineral density in elderly women. J Clin Densitom. 2018;21:193-199.
Williams LJ, Berk M, Hodge JM, et al. Selective serotonin reuptake inhibitors (SSRIs) and markers of bone turnover in men. Calcif Tissue Int. 2018;103:125-130.
Kumar M, Jiloha RC, Kataria D, Prasad S, Vohora D. Effect of selective serotonin reuptake inhibitors on markers of bone loss. Psychiatry Res. 2019;276:39-44.
Lavoie B, Lian JB, Mawe GM. Regulation of bone metabolism by Serotonin. Adv Exp Med Biol. 2017;1033:35-46.
Agacayak KS, Guler R, Ilyasov B. Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography. Drug Des Devel Ther. 2019;13:3477-3484.
Hakam AE, Vila G, Duarte PM, et al. Effects of different antidepressant classes on dental implant failure: a retrospective clinical study. J Periodontol. 2021;92:196-204.
Deepa MujawarK, Dhillon K, Jadhav P, et al. Prognostic implication of selective serotonin reuptake inhibitors in osseointegration of dental implants: a 5-year retrospective study. J Contemp Dent Pract. 2018;19:842-846.
Altay MA, Sindel A, Özalp Ö, et al. Does the intake of selective serotonin reuptake inhibitors negatively affect dental implant osseointegration? A retrospective study. J Oral Implantol. 2018;44:260-265.
Carr AB, Gonzalez RLV, Jia L, Lohse CM. Relationship between selective serotonin reuptake inhibitors and risk of dental implant failure. J Prosthodont. 2019;28:252-257.
Coelho JMF, Miranda SS, da Cruz SS, et al. Common mental disorder is associated with periodontitis. J Periodontal Res. 2020;55:221-228.
Liu F, Wen YF, Zhou Y, et al. A meta-analysis of emotional disorders as possible risk factors for chronic periodontitis. Medicine (Baltimore). 2018;97:e11434.
Coşgunarslan A, Aşantoğrol F, Soydan Çabuk D, Canger EM. The effect of selective serotonin reuptake inhibitors on the human mandible. Oral Radiol. 2021;37:20-28.
Glossary of endodontic terms. American Association of Endodontists, 10th ed. Chicago IL; 2020:4.
Nalliah RP, Allareddy V, Elangovan S, et al. Hospital emergency department visits attributed to pulpal and periapical disease in the United States in 2006. J Endod. 2011;37:6-9.
Sheskin DJ. Handbook of Parametric and Nonparametric Statistical Procedures. 5th ed. Chapman & Hall /CRC; 2011:761-804.
Daly C. Oral and dental effects of antidepressants. Aust Prescr. 2016;39:84.
Cockburn N, Pradhan A, Taing MW, Kisely S, Ford PJ. Oral health impacts of medications used to treat mental illness. J Affect Disord. 2017;223:184-193.
Das S, Sekharan L. Recurrent dental infection due to use of SSRIs: a case report. Psychiatr Danub. 2021;33:196-197.
Banting DW, Papas A, Clark DC, et al. The effectiveness of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry mouth. Gerodontology. 2000;17:67-76.
Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J. 2010;55:238-244.
Patel PS, Ghezzi EM, Ship JA. Xerostomic complaints induced by an anti-sialogogue in healthy young vs. older adults. Spec Care Dentist. 2001;21:176-181.
Thomson WM. Dry mouth and older people. Aust Dent J. 2015;60(1):54-63.
Warden SJ, Robling AG, Haney EM, Turner CH, Bliziotes MM. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone. 2010;46:4-12.
Ducy P, Karsenty G. The two faces of serotonin in bone biology. J Cell Biol. 2010;191:7-13.
Oury F, Yadav VK, Wang Y, et al. CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev. 2010;24:2330-2342.
Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med. 2007;167:1240-1245.
Kanis JA. Diagnosis of osteoporosis. Osteoporos Int. 1997;7:108-116.
Katz J, Rotstein I. Prevalence of periapical lesions in patients with osteoporosis. J Endod. 2021;47:234-238.
Hahad O, Beutel M, Gilan DA, et al. The association of smoking and smoking cessation with prevalent and incident symptoms of depression, anxiety, and sleep disturbance in the general population. J Affect Disord. 2022;313:100-109.